alexa Application Of Nanomedicine In The Treatment Of Malaria
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference on Nanotek & Expo
December 02-04, 2013 Hampton Inn Tropicana, Las Vegas, NV, USA

Melariri Paula, Lonji Kalombo, Patric Nkuna, Rose Hayeshi, Admire Dube, Lubbe Wiesner, Peter Smith and Hulda Swai
ScientificTracks Abstracts: J Nanomed Nanotechnol
DOI: 10.4172/2157-7439.S1.013
Abstract
Malaria is one of the world?s deadliest infectious diseases. Each year over 1.5 million people die and an estimated 40% of the world?s population is at risk. Over 90% of deaths occur in sub-Saharan Africa where on average a child dies of malaria every 12 seconds. Currently no effective vaccine against malaria is available. A major reason for the failure to eradicate malaria has been the shortcomings of malaria preventive and curative drug treatments. Nanomedicine is a new technology utilizing nanometre scale (generally 100 nm) drug delivery systems as therapeutics, able to confer advantages which include improved drug pharmacokinetic profiles (improved absorption, bioavailability, elimination half-life), organ, cell and parasite targeted drug delivery, and reduction in drug toxicity. Nanomedicine can address the challenges of current antimalarials, by reformulating the drugs in nanomedicine drug delivery systems (NMDDS). Nanomedicine has already impacted other diseases, e.g. cancer, exemplified by the reformulation of doxorubicin to provide a potent and extended half-life therapy with reduced side effects. Our vision is to see nanomedicine do the same for malaria chemotherapy, radically improving treatment outcomes using currently available drugs, saving lives, and advancing the global goal of eradicating malaria. Results from our preliminary studies in mice, using our novel NMDDS recorded significant enhancement, in the pharmacokinetic properties of drugs reformulated in NMDDS when compared to the non-formulated drugs.
Biography
Melariri Paula completed her Ph.D. in 2010 at the University of Cape Town, South Africa. She is a Senior Researcher and malaria project manager in the Encapsulation and Drug Delivery group, Council for Scientific and Industrial Research, South Africa. She is leading the research activities in developing novel nanomedicine treatments for malaria. She is passionate about neglected tropical diseases and infectious diseases of poverty. She has published several articles and is a reviewer to several journals
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]e.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords